Unknown

Dataset Information

0

CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression.


ABSTRACT: Luminal B breast cancers (BC) have a more aggressive behavior associated with a higher rate of tumor relapse and worse prognosis compared to luminal A tumors. In this study, we evaluated the involvement of specific epithelial-to-mesenchymal transition- (EMT-) and immune-related pathways in the dissemination of luminal B BC cells. The expression of 42 EMT- and immune-related genes was evaluated in matched sentinel lymph nodes (SLNs) analyzed by the one-step nucleic acid amplification assay (OSNA) and primary tumors of 40 luminal B BC patients by gene array and immunohistochemistry. The results were validated in an independent group of 150 luminal B tumors by immunohistochemistry and immunofluorescence and using gene expression data from 315 luminal B BC patients included in the Metabric dataset. We found that the expression of CXCR4 (p = 3.28E - 02) and CD163 (p = 6.92E - 03) was significantly upregulated in SLNs of recurrent luminal B BC patients. Luminal B primary tumors overexpressing CXCR4 were characterized by an increased expression of vimentin and a high content of CD163-positive macrophages. Bioinformatics analysis confirmed the correlation of CXCR4 with CXCL12, VIM, and CD163 expression and LN involvement. Our results suggest that the upregulation of the CXCR4/CXCL12 pathway and the presence of protumor macrophages in the primary tumor and SLNs sustain the aggressiveness of an important subgroup of luminal B BC.

SUBMITTER: Raschioni C 

PROVIDER: S-EPMC5926522 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression.

Raschioni Carlotta C   Bottai Giulia G   Sagona Andrea A   Errico Valentina V   Testori Alberto A   Gatzemeier Wolfgang W   Corsi Fabio F   Tinterri Corrado C   Roncalli Massimo M   Santarpia Libero L   Di Tommaso Luca L  

Disease markers 20180416


Luminal B breast cancers (BC) have a more aggressive behavior associated with a higher rate of tumor relapse and worse prognosis compared to luminal A tumors. In this study, we evaluated the involvement of specific epithelial-to-mesenchymal transition- (EMT-) and immune-related pathways in the dissemination of luminal B BC cells. The expression of 42 EMT- and immune-related genes was evaluated in matched sentinel lymph nodes (SLNs) analyzed by the one-step nucleic acid amplification assay (OSNA)  ...[more]

Similar Datasets

| S-EPMC7795445 | biostudies-literature
| S-EPMC6277398 | biostudies-literature
| S-EPMC2874457 | biostudies-literature
| S-EPMC3928050 | biostudies-literature
| S-EPMC5684437 | biostudies-literature
| S-EPMC4457868 | biostudies-literature
| S-EPMC5027880 | biostudies-other
| S-EPMC8805599 | biostudies-literature
| S-EPMC10391974 | biostudies-literature
| S-EPMC7280473 | biostudies-literature